Pertuzumab biosimilar（Biocon）
帕妥珠单抗生物类似药（Biocon）
Report date: 2026/03/14 20:00:17
Base Information
Drug NamePertuzumab biosimilar（Biocon）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiocon Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBiocon Ltd
Inactive CompaniesBiocon Biologics Ltd
Active Indications
Inactive IndicationsN/A